What companies are CRBU's competitors?

Caribou Biosciences, Inc. (CRBU)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.

How does CRBU compare to its peers?

The peer comparison table on this page shows Caribou Biosciences, Inc. (CRBU) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.

What sector does CRBU operate in?

Caribou Biosciences, Inc. (CRBU) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

CRBU

Caribou Biosciences, Inc.

NASDAQ·Biotechnology · Healthcare

$1.65$0.11−6.25%

Pre-market·$1.69+2.42%

Market cap$163.65M·Market closed·Aug 26 8:00 PM UTC

Frequently Asked Questions About CRBU

What companies are CRBU's competitors?: Caribou Biosciences, Inc. (CRBU)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does CRBU compare to its peers?: The peer comparison table on this page shows Caribou Biosciences, Inc. (CRBU) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does CRBU operate in?: Caribou Biosciences, Inc. (CRBU) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

CRBU

Caribou Biosciences, Inc.

NASDAQ·Biotechnology · Healthcare

$1.65$0.11−6.25%

Pre-market·$1.69+2.42%

Market cap$163.65M·Market closed·Aug 26 8:00 PM UTC

Peers


ALLO	Allogene Therapeutics, Inc.	$2.04	$704.1M
ENTA	Enanta Pharmaceuticals, Inc.	$14.15	$411.5M
FHTX	Foghorn Therapeutics Inc.	$6.69	$392.8M
PRLD	Prelude Therapeutics Incorporated	$6.56	$373.5M
OBIO	Orchestra BioMed Holdings, Inc.	$5.26	$315.0M
IVA	Inventiva S.A.	€4.82	€250.6M
PYXS	Pyxis Oncology, Inc.	$3.34	$211.6M
TNYA	Tenaya Therapeutics, Inc.	$0.70	$151.1M
AARD	Aardvark Therapeutics, Inc. Common Stock	$6.81	$149.0M
HUMA	Humacyte, Inc.	$0.68	$114.5M

Frequently Asked Questions About CRBU

What companies are CRBU's competitors?: Caribou Biosciences, Inc. (CRBU)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does CRBU compare to its peers?: The peer comparison table on this page shows Caribou Biosciences, Inc. (CRBU) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does CRBU operate in?: Caribou Biosciences, Inc. (CRBU) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.